Nicole Lambert - Dec 8, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.
Signature: By: Nathan A. Smith For: Nicole Lambert
Stock symbol: MYGN
Transactions as of: Dec 8, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/10/2021, 03:39 PM
Previous filing: Oct 12, 2021
Next filing: Feb 18, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MYGN	Common Stock	Award	$0	+10K	+6.08%	$0.00	174K	Dec 8, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments on January 1, 2023, January 1, 2024, January 1, 2025, and January 1, 2026.
F2	Includes 317 shares of Myriad common stock that were omitted from the reporting person's Form 3, which was amended to reflect such shares on November 1, 2021.

Remarks:

Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.